NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/24/2025
Back to search
Official data from USPTO
YUVIWEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
06/24/2025
Trademark type
Word
Nice classes
5, 10
Filing date
06/24/2024
Registration date
06/24/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/24/2025
Last transaction
06/24/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Hellerup, DK
Examiner
HACK, ANDREA R
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Ascendis Pharma Growth Disorders A/S
Representatives
Shannon Marie McKeon Dykema Gossett PLLC
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of growth disorders; pharmaceutical preparations for the treatment of endocrine disorders; pharmaceutical preparations for the treatment of bone disorders; pharmaceutical preparations for the treatment of skeletal disorders; pharmaceutical preparations for the treatment of genetic disorders affecting bone and skeletal growth; pharmaceutical preparations for the treatment of osteochondrodysplasiaachondroplasia and hypochondroplasia; diagnostic preparations for medical usediagnostic preparations for identifying and detecting growth disordersendocrine disordersbone disordersskeletal disordersosteochondrodysplasiaachondroplasia and hypochondroplasia
Class 10
Drug delivery devices sold emptymedical devices for injectionsyringes for injectioninfusion and injection devices for administering drugs that control the dosage of pharmaceuticals for the treatment of growth disordersendocrine disordersbone disordersskeletal disordersosteochondrodysplasiaachondroplasia and hypochondroplasia; medical devices for dosage and injection of pharmaceutical and medical preparationsnamely pen-type syringesmedical auto-injectorsautoinjector syringesinjection needlesautoinjector cartridges; Syringes for medical purposes and for injections; Syringes for injection for medical usenamely syringes in the form of pens for medical and surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of skeletal disordersosteochondrodysplasiaachondroplasia and hypochondroplasianamely displaysmonitorscontrollers for medical fluid injectors; Medical apparatusinfusion and injection devices for administering drugs; Apparatus and instruments for medical diagnostic purposesdosage management dispensers for medicines containing pre-embedded or installed software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; Dosage management dispensers for administering medicine to patients containing pre-installed or embedded software for medical information managementfor guidance and control of medicinesfor therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/24/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/06/2025
PUBO
PUBLISHED FOR OPPOSITION
05/06/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/30/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
04/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/27/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/27/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/27/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/27/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/11/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/11/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/23/2024
GNRT
NON-FINAL ACTION E-MAILED
12/23/2024
CNRT
NON-FINAL ACTION WRITTEN
12/23/2024
DOCK
ASSIGNED TO EXAMINER
12/23/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/24/2024
NWAP
NEW APPLICATION ENTERED
06/24/2024
Continuous trademark protection
Get notified about every new filing that threatens YUVIWEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.